Animalcare Group Plc

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB0032350695
GBP
2.49
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Animalcare Group Plc stock-summary
stock-summary
Animalcare Group Plc
Pharmaceuticals & Biotechnology
Animalcare Group plc is a United Kingdom-based sales, marketing and product development company. The Company is principally engaged in the development, sale and distribution of licensed veterinary pharmaceuticals and identification products and services to companion animal veterinary markets. The Company develops and sells goods and services to veterinary professionals principally for use in companion animals, operating through the United Kingdom wholesalers and distribution and development partners in markets in Western Europe. The Company's product portfolio is divided into three product groups: pharmaceuticals (Licensed Veterinary Medicines); pet microchips (Companion Animal Identification), and consumable items (Animal Welfare Products). Animalcare Ltd is the Company's subsidiary. It has operations in the United Kingdom, Europe and Rest of World.
Company Coordinates stock-summary
Company Details
7 Unit York Business Park, 10 Great North Way YORK None : YO26 6RB
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Jan Boone
Non-Executive Chairman of the Board
Ms. Jennifer Winter
Chief Executive Officer, Executive Director
Mr. Chris Brewster
Chief Financial Officer, Executive Director, Company Secretary
Mr. Chris Cardon
Non-Executive Director
Mr. Marc Coucke
Non-Executive Director
Lord Nick Downshire
Independent Non-Executive Director
Mr. Edwin Torr
Senior Non-Executive Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

GBP 172 Million (Small Cap)

stock-summary
P/E

34.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.09%

stock-summary
Debt Equity

0.08

stock-summary
Return on Equity

3.93%

stock-summary
Price to Book

1.52